Skip to main content

Table 4 Cox regression analyses of overall survival in CSCC patients

From: HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer

Factors OS (univariate analysis) OS (multivariate analysis)
HR (95% CI) P-value HR (95% CI) P-value
Age 1.755 (0.845–3.645) 0.131
Stage 1.281 (0.625–2.625) 0.499
Tumor size 1.307 (0.637–2.680) 0.466
Tumor type 1.279 (0.872–1.877) 0.208
Histologic grade 0.863 (0.572–1.302) 0.482
HPV 1.509 (0.671–3.394) 0.320
Pelvic lymph nodes 2.186 (1.037–4.605) 0.040 2.053 (0.958–4.397) 0.064
Therapy 0.475 (0.232–0.975) 0.042 0.425 (0.205–0.881) 0.021
Multiple overlapping-peptide response 0.227 (0.031–1.666) 0.145 0.307 (0.040–2.352) 0.256
HLA A*02:07 3.042 (1.348–6.862) 0.007 2.914 (1.270–6.686) 0.012
  1. HPV, human papillomavirus; HLA, human leukocyte antigen